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Abstract
Background: Gastroschisis research is limited in quality by the presence of significant heterogeneity in outcome
measure reporting (PloS One 10(1):e0116908, 2015). Using core outcome sets in research is one proposed method
for addressing this problem (Trials 13:103, 2012; Clin Rheumatol 33(9):1313-1322, 2014; Health Serv Res Policy 17(1):
1-2, 2012). Ultimately, standardising outcome measure reporting will improve research quality and translate into
improvements in patient care.
Methods/design: Candidate outcome measures have been identified through systematic reviews. These outcome
measures will form the starting point for an online, three-phase Delphi process that will be carried out in parallel by
three panels of experts. Panel 1 is a neonatal panel, panel 2 is a non-neonatal panel and panel 3 is a lay panel.
In round 1, experts will be asked to score the previously identified outcome measures from 1–9 based on how
important they think the measures are in determining the overall success of their/their child’s/their patient’s
gastroschisis treatment.
In round 2, experts will be presented with the same list of outcome measures and with graphical representations of
how their panel scored that outcome in round 1. They will be asked to re-score the outcome measure taking into
account how important other members of their panel felt it to be. In round 3, experts will again be asked to
re-score each outcome measure, but this time they will receive a graphical representation of the distribution of
scores from all three panels which they should take into account when re-scoring.
Following round 3 of the Delphi process, 40 experts will be invited to attend a face-to-face consensus meeting.
Participants will be invited in a purposive manner to obtain balance between the different panels. The results of the
Delphi process will be discussed, and outcomes re-scored. Outcome measures where > 70 % of the participants at
the meeting scored them as 7–9 and < 15 % scored them as 1–3 will form the core outcome set.
Discussion: Development of a core outcome set will help to reduce the heterogeneity of the outcome measure
reporting in gastroschisis. This will increase the quality of research taking place and ultimately improve care
provided to infants with gastroschisis.
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Background
Gastroschisis is an increasingly common paediatric surgi-
cal condition, which now affects approximately 1:3000 live
births in the UK [1]. Mortality for infants with gastroschi-
sis is relatively low [2]. However, the initial inpatient stay
for these infants is the longest of any of the commonly en-
countered birth defects [3], and children are often affected
by significant long-term morbidity in the form of repeat
operations, need for enteral feeding assistance and paren-
teral nutrition use [2, 4]. The cost to the NHS of man-
aging infants with gastroschisis is also significant, with
their initial inpatient stay costing approximately £90,000,
and any subsequent unplanned operations under the age
of one costing approximately £25,000 [5, 6].
Multiple surgical repair strategies exist for the treatment
of gastroschisis, with the two most common being opera-
tive primary fascial closure and silo placement with staged
reduction and delayed closure [1]. Currently, significant
heterogeneity exists in outcome measure reporting in
studies comparing these two key interventions for gastro-
schisis (Allin BSR, Irvine A, Patni N, Knight M: Variability
of outcome reporting in Hirschsprung’s Disease and gas-
troschisis: a systematic review, unpublished). Such hetero-
geneity has led to studies focusing on surrogate markers
of treatment success, short-term outcomes or hospital
metrics, as opposed to outcomes that are of relevance to
patients or that impact the long-term quality of life [7, 8].
This lack of patient relevance is one of three problems
caused by heterogeneity in outcome measure reporting;
the other two are a risk of reporting bias and an inability
to synthesise data arising from multiple studies.
For gastroschisis, where little research is taking place
and where the majority of that research is of a small sam-
ple size, reported outcomes should be relevant, accurately
represent the studies’ findings and be synthesisable
through meta-analysis. If reported outcomes do not meet
these standards, the derivation of robust, evidence-based
management guidelines for infants with gastroschisis will
be impossible. A lack of such guidelines may contribute to
the wide variation in management and outcomes for
infants with gastroschisis specifically and for infants
requiring early surgery more generally [1, 2, 9–11].
The COMET (Core Outcome Measures in Effectiveness
Trials) initiative was established to bring together people
with an interest in the development and application of
agreed upon standardized sets of outcome measures,
known as core outcome sets [12, 13]. Core Outcome Sets
are groups of outcome measures, commonly identified
through a Delphi process and ratified by key stakeholders,
as the outcomes that minimally should be reported in
every study of a given condition [13]. Core outcome sets
have already been developed for conditions as diverse as
ankylosing spondylitis and asthma and have been shown
to improve the quality of research taking place [14, 15].
Development of a core outcome set for use in gastro-
schisis would standardise outcome reporting, reduce
reporting bias, improve patient relevance and facilitate
meta-analysis. Addressing these points would signifi-
cantly improve the quality of research taking place and,
when combined with improved collaboration between
research institutions, allow for the development of
evidence-based management guidelines.
Methods/design
Ethics and registration
The Health Research Authority deemed the project to
be Service Evaluation/Service Development and there-
fore review by an NHS Research Ethics Committee is
not necessary. Information on the nature of the study
is provided to participants prior to registration and
again prior to completion of the first round of the
survey. Potential participants are given contact details
for staff within the National Perinatal Epidemiology
Unit from whom further information can be obtained
or with whom they can discuss the study further. De-
tailed information is also available on the study web-
site (www.npeu.ox.ac.uk/nets). Consent to participate
in the study is implied by completion of the registra-
tion questionnaire and data-collection questionnaires.
Participants can withdraw from the study at any time
either by contacting the study team or by simply not
completing a data-collection questionnaire. The study
has been registered with the COMET initiative
(www.comet-initiative.org).
Scope of the core outcome set
The developed core outcome set is intended to be used
to assess the overall success of treatment of an infant
born with gastroschisis. This will involve outcome mea-
sures identified as important from birth into adulthood.
The core outcome set is not intended to be applicable to
antenatal interventions or interventions related to the
mode or timing of delivery.
Key objectives
1. Determine which outcomes are currently reported
in studies comparing surgical treatments for
gastroschisis and assess the quality of reporting
2. Prioritise outcomes from patient/parent, paediatric
surgical and non-surgical clinician perspectives
3. Achieve consensus between key stakeholders on a
core outcome set for assessing how successful the
overall treatment of an infant with gastroschisis has
been
4. Compare and contrast outcomes prioritised by
patients/parents, surgeons and non-surgical
clinicians
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Wider aims
1. A wider aim is to develop methodology for
countering difficulties likely to be seen in the
development of core outcome sets in all paediatric
surgical conditions, including the following:
a. Recruitment of parents and patients
b. Incorporation of opinions from clinicians whose
priorities vary dependent on their specialty or on
the age at which they encounter the child.
Design
Four key stages occur in the development of the core
outcome set:
1. Systematic review to identify currently reported
outcomes
2. Development of a panel of experts
3. Three-phase online Delphi process
4. Consensus meeting
Systematic review
Two systematic reviews comparing methods of treat-
ment for gastroschisis have been conducted. The first
was a systematic review of broad scope, including both
observational and experimental study designs (Allin
BSR, Irvine A, Patni N, Knight M: Variability of outcome
reporting in Hirschsprung’s Disease and gastroschisis: a
systematic review, unpublished), whilst the second fo-
cussed on randomised controlled trials and systematic
reviews of randomised controlled trials [16]. Outcome
measures in these reviews will be used as the starting
point for the development of the core outcome set. The
developed core outcome set is intended to be relevant to
post-natal interventions only. Therefore, any outcome
measures identified from the systematic reviews that are
deemed relevant only to antenatal interventions or inter-
ventions relating to mode and timing of delivery will not
be carried forward to phase 1 of the Delphi process.
Panel assembly – expert identification and recruitment
Panel assembly will be based on methods developed by
Okoli et al. [17]. A knowledge resource nomination work-
sheet will be developed by members of the study manage-
ment group. A knowledge resource nomination worksheet
is used to ensure that experts are recruited across an ad-
equate breadth of experience of gastroschisis. Initially,
areas from which experts must be recruited will be identi-
fied under the headings of ‘Disciplines, Organisations and
Literature’. Members of the study management group will
populate each of these headings with categories of experts
from which participants must be recruited. Examples of
categories include ‘paediatric surgeons’, ‘parents’, ‘the Royal
College of Paediatrics and Child Health’, and the ‘Journal
of Paediatric Surgery’. Once the study management group
has developed an exhaustive list of categories, an iterative
process will be used to populate each category with names
of potential experts. Initially, experts known to the study
management group will be added to the knowledge re-
source nomination worksheet. Strategies to identify fur-
ther experts in each category will then be developed.
These strategies will differ from category to category, but
some examples include those listed below.
Paediatric surgeons
Potential experts will include those identified as having
an interest in managing infants with gastroschisis on a
search of the British Association of Paediatric Surgeons
register of practitioners. The clinical leads for each of
the 27 paediatric surgical centres in the UK will be iden-
tified via the websites of those centres and will also be
considered potential experts.
Neonatologists and paediatricians
Heads of department for all level 2 and level 3 neonatal
units and their associated paediatric departments in the
UK will be identified via the websites for these NHS
trusts and will be considered potential experts.
Parents and patients
A parent advisory group has been established in the Na-
tional Perinatal Epidemiology Unit. This group consists
of parents of infants who have required early surgery,
including those with gastroschisis, exomphalos, Hirsch-
sprung’s Disease and anorectal malformations. Parents
of infants with gastroschisis will be identified via the
mailing list for this group. Additional parents/infants
will be identified through use of the Gastroschisis, Exom-
phalos, and Exstrophy Parent Support mailing lists and
Facebook groups. Members of the study management
group, as well as the British Association of Paediatric
Surgeons Congenital Anomalies Surveillance System
steering committee, including BA, NH and SM, will be
utilised to recruit infants and parents from their respect-
ive hospitals to give good representation from all regions
in the UK. Parents/patients identified in each of these
ways will be considered potential experts.
Journals
Editors of key paediatric and paediatric surgical journals
will be considered potential experts. They will also be
asked to identify any members of their editorial board
who have expertise in gastroschisis.
Using similar strategies for each remaining category,
the knowledge resource nomination worksheet will be
populated with a master list of potential experts. Each
person named on the knowledge resource nomination
worksheet will be sent an information pack via email. In
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these information packs, we will explain that we have
identified the recipient as someone with expertise in the
management of infants with gastroschisis and that we
are seeking to establish whether the recipient is be suit-
able for and interested in participating in development
of a core outcome set. The information packs will also
contain a plain language summary of the COMET initia-
tive and a lay or scientific summary of the study as ap-
propriate. A link will be provided to an online form for
experts to express their interest in participation in the
study and to provide more information on their involve-
ment in management of infants with gastroschisis. Each
expert will also be asked to provide the names and con-
tact details of anyone else they believe would be suitable
for inclusion in the study. At this stage, we are seeking
to clarify the suitability of experts for participation in
the study and to identify further potential experts. This
process will be repeated for the names provided by the
previously contacted experts. Expert recruitment will
continue until a minimum of 50 experts, with at least
two in each category, has been recruited.
Following confirmation of their eligibility to participate
in the study, experts will be sent a link to a customised
online database from which they can access phase 1 of
the Delphi process.
Scope of expert recruitment
An a priori decision has been made to limit recruitment
of experts to those based in the UK.
Panel assembly – facilitating consensus
Clinicians who treat gastroschisis in the neonatal period,
such as paediatric surgeons, may have a different set of
priorities than those who primarily manage affected chil-
dren later in life, such as paediatricians. This may make
it difficult to attain their consensus on a single set of
outcome measures. It is essential that the core outcome
set represent the views of patients/parents, neonatal cli-
nicians and non-neonatal clinicians. To ensure that this
occurs, experts will be separated into the following three
panels:
 Neonatal panel – clinicians whose responsibility
includes management in the neonatal period (but
may also include management outside of the
neonatal period). This group will include
neonatologists and paediatric surgeons.
 Non-neonatal panel – researchers with expertise in
gastroschisis management and clinicians responsible
for management primarily outside of the neonatal
period. This group will include specialist nurses and
paediatricians.
 Lay panel – parents, and adults who were born with
gastroschisis.
Delphi process – phase 1 data collection
An online system will be used to conduct a three-phase
Delphi process run in parallel for the ‘neonatal’ , ‘non-
neonatal’ and ‘lay’ panels. An online system has been
chosen in order to maintain anonymity, where experts
do not know the names of other experts on their panel
or other experts’ individual responses.
In phase 1a, participants will be presented in alphabet-
ical order with the list of outcomes identified through
the systematic reviews. The study management group
will develop equivalent lay terms for each scientific out-
come, and their understanding will be piloted with the
National Perinatal Epidemiology Unit’s parent advisory
group. These lay terms will be used instead of scientific
terms in the questionnaires completed by the lay panel.
If there is ambiguity over the outcome or domain, either
in the scientific or lay questionnaire, ‘tips’ will be placed
alongside them to clarify meaning.
Participants will be asked to give each outcome meas-
ure a score from 1–9 where 1, 2 and 3 are ‘not that im-
portant’; 4, 5 and 6 are ‘important’; and 7, 8 and 9 are
‘really important’.
The Grading of Recommendations Assessment, Devel-
opment and Evaluation Working Group scale of meas-
urement has been chosen for use in scoring outcome
measures, based on recommendations from the COMET
initiative [18].
Following completion of phase 1a, participants will be
asked if there are any outcomes they consider important
in determining whether treatment of their/their child’s/
their patient’s gastroschisis has been successful, but
which we have not yet identified. They will be able to list
as many items as they consider necessary.
A planned period of 4 weeks will be scheduled for
completion of data collection in phase 1 and for each
subsequent phase. When experts have not returned their
completed questionnaire within 2 weeks of the start of
the phase, they will be contacted via email to remind
them of the necessity to complete the phase. If they have
not completed the questionnaire by the 3-week deadline,
they will be contacted again via email to ascertain if they
are having difficulties in completing the questionnaire or
if they have decided they no longer want to participate
in the study. Participants who have not completed the
questionnaire within 4 weeks of the phase starting will
be deemed not to have completed that phase.
Delphi process – phase 1 analysis
The number of experts invited to participate, register-
ing to participate, and completing phase 1 of the Del-
phi process from each category identified in the
knowledge resource nomination worksheet will be
recorded.
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Two reviewers will independently assess outcomes re-
ported in phase 1b in order to determine if they repre-
sent de novo outcomes not already listed in phase 1a.
De novo outcomes listed by at least one expert will be
taken forward to phase 2 of the Delphi process.
Outcomes will be analysed separately for each panel
with descriptive statistics, including medians and inter-
quartile ranges, being calculated. All outcomes will be
carried forward to phase 2.
Phase 2 data collection
Experts completing phase 1 will be invited to participate
in phase 2 and asked to re-score each outcome based on
the following:
 The phase 1 score they assigned it
 Descriptive statistics from their panel
Descriptive statistics will be represented numerically
and graphically.
Phase 2 analysis
Descriptive statistics will again be calculated. Bias from
loss of experts between rounds will be assessed by deter-
mining if there is any difference in median round 1
scores for each outcome measure between experts who
have completed both phases and experts who only com-
pleted phase 1. All outcomes will be carried forward to
phase 3.
Phase 3 data collection
Experts completing phase 2 will be invited to participate
in phase 3 and will be asked to re-score each outcome
based on the following:
 The phase 2 score they assigned it
 Round 2 descriptive statistics from all three panels
Phase 3 analysis
Analysis will be conducted as per phase 2.
Generation of core outcome set – consensus meeting
Experts who have completed all three phases of the Del-
phi process will be invited to the consensus meeting
purposively with an even spread across panels and disci-
plines until 40 experts have confirmed their attendance.
The intention of the consensus meeting is to ratify the
established core outcome set, discuss outcomes where
no consensus could be obtained and determine the most
appropriate methods and timing for assessing the identi-
fied core outcomes. The consensus group will also dis-
cuss how identified core outcomes relate to the core
areas within the OMERACT filter 2.0.
Following discussion of outcomes, each outcome will
be re-scored anonymously and electronically by the
meeting participants using the same scoring system as
for the Delphi process. Participants will be asked to re-
score outcomes based on their own scores, the results of
the Delphi process and the discussions at the meeting.
Outcomes reaching ‘consensus in’ as defined below fol-
lowing re-scoring at the consensus meeting will be in-
cluded in the core outcome set. All others will be
excluded.
Outcomes will be discussed at the consensus meeting
in different groups according to the number of panels in
which they have reached ‘consensus in’ at the end of the
third phase of the Delphi process. ‘Consensus in’ will be
defined as ≥ 70 % of participants rating the outcome 7–
9, and < 15 % rating it as 1–3. Outcomes will additionally
be classified as ‘consensus out’ if > 70 % participants
rated it 1–3 and < 15 % rated it 7–9. All other outcomes
will be considered as not achieving consensus in either
direction. Only ‘consensus in’ outcomes will form part of
the core outcome set.
Table 1 SPIRIT Table
Study period
Enrolment Allocation to Panel 1,
2 or 3 According to
Specialty
Post-allocation Close-out
Timepoint December
2015-February 2016
February 2016 Round 1
(Feb–March 2016)
Round 2
April–May 2016
Round 3
May–June 2016
Consensus meeting
221 June 2016
July 2016
Enrolment: X
Eligibility screen X
Implied consent
through registration
X
(List other procedures)
Allocation X
Assessments:
(Outcome scores) X X X X
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Compliance with SPIRIT recommendations can be
seen in the SPIRIT checklist (Additional file 1), and the
SPIRIT Table (Table 1).
Sub-group analysis
Paediatric surgeons are broadly responsible for deter-
mining which initial treatment strategy should be under-
taken for infants with gastroschisis. They are also
responsible for implementing this intervention. We are
interested to see whether their views on outcomes of im-
portance are different from those of clinicians whose pri-
mary role is in the treatment of the complications of
gastroschisis or in monitoring of longer-term outcomes
for infants with gastroschisis. In order to do this, we will
perform a sub-group analysis comparing phase 3 scores
for paediatric surgeons with phase 3 scores for non-
surgical clinicians.
Following completion of the consensus meeting, a
consensus document will be drafted and put forward to
participants for approval. This document will be pre-
sented at appropriate international meetings and pub-
lished in peer-reviewed journals.
Data management
All data will be directly entered into a customised data-
base by participants. Data will be stored securely on
servers within the National Perinatal Epidemiology Unit
and will be managed as per standard operating proto-
cols. Only appropriate members of the study team will
have access to the data. Data analysis will be conducted
by BA and MK.
Discussion
No core outcome set currently exists for use in deter-
mining how successful the overall treatment of a child’s
gastroschisis has been. Development of one will stand-
ardise outcome measure reporting, thereby increasing
patient relevance of research, reducing reporting bias,
and increasing ease of data synthesis. Involvement of
multiple key stakeholder groups in the development of
the core outcome set will help ensure its validity and
generalisability. Through implementation of the core
outcome set, key clinical questions will be more readily
answerable. Ultimately, this will aid identification of
evidence-based treatments, improve outcomes for in-
fants with gastroschisis and improve the quality of coun-
seling of their parents.
Study status
Participant recruitment has started.
Additional file
Additional file 1: Spirit Checklist. This file contains the completed SPIRIT
checklist describing where key portions of text can be identified in the
protocol. (DOC 121 kb)
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